This paper proposes a concrete chemical implementation of the Φ‑stable theory of life, which defines living systems by four simultaneous closure conditions: persistent asymmetric records (C1), localized construction exceeding destruction (C2), a self‑produced boundary (C3), and template‑directed replication (C4). Rather than invoking a single “magic” molecule, we introduce a distributed catalyst pipeline: a sequence of catalytic stages that collectively implement all four conditions within the same chemical hardware. The pipeline architecture consists of (i) state inversion, (ii) molecular information encoding, (iii) memory fixation via hysteresis, and (iv) erasability/reset. Each stage is grounded in experimentally demonstrated chemistry, including photodynamic and organocatalytic inversion, recombinase‑based memory, multicomponent molecular information storage, dynamic combinatorial libraries with chemical hysteresis, and reconfigurable nucleic acid catalytic networks. We show how these mechanisms can be coupled into a non‑equilibrium, hysteretic, erasable architecture that realizes a Φ‑stable fixed point. The framework yields testable, falsifiable predictions: the coupled four‑stage pipeline should outperform any isolated stage; spatial colocalization of catalysts should enhance efficiency; hysteresis should appear only above a threshold energy flux; erasability should enable evolvable information; and, crucially, an abrupt functional onset is expected when all four stages are fully coupled, in contrast to incremental‑assembly models that predict gradual improvement. An experimental roadmap is provided, including stage‑by‑stage implementations, success criteria, and resource estimates. The decisive experiment is the assembly of all four stages in a single chemical substrate under sustained energy flux, which will determine whether the distributed catalyst pipeline is a viable chemical realization of the Φ‑stable transition.
Luiz PUODZIUS (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: